Definitive Healthcare Corp. (DH)
NASDAQ: DH · Real-Time Price · USD
2.710
+0.100 (3.83%)
Apr 24, 2025, 4:00 PM EDT - Market closed

Company Description

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally.

Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.

The company’s platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management.

It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem.

Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.

Definitive Healthcare Corp.
Definitive Healthcare logo
Country United States
Founded 2011
IPO Date Sep 15, 2021
Industry Health Information Services
Sector Healthcare
Employees 782
CEO Kevin Coop

Contact Details

Address:
492 Old Connecticut Path, Suite 401
Framingham, Massachusetts 01701
United States
Phone 508 720 4224
Website definitivehc.com

Stock Details

Ticker Symbol DH
Exchange NASDAQ
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
IPO Price $27.00
CIK Code 0001861795
CUSIP Number 24477E103
ISIN Number US24477E1038
SIC Code 7372

Key Executives

Name Position
Kevin D. Coop Chief Executive Officer and Director
Jason Ronald Krantz Founder and Executive Chairman
Kate Marie Shamsuddin Jensen Chief Operating Officer
Matthew Ruderman Chief Legal Officer and Secretary
Michelle Liro Senior Vice President of Marketing
Casey Heller Senior Vice President of Finance
Rebecca Marani GM and Senior Vice President of Provider
Kate Hastings Chief Customer Officer
Sally Slarke Senior Vice President of Commercial Center of Excellence
Marissa Peoples Odell Senior Vice President of Diversified

Latest SEC Filings

Date Type Title
Apr 23, 2025 ARS Filing
Apr 23, 2025 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 23, 2025 DEF 14A Other definitive proxy statements
Feb 27, 2025 S-8 Securities to be offered to employees in employee benefit plans
Feb 27, 2025 10-K Annual Report
Feb 27, 2025 8-K Current Report
Feb 13, 2025 SCHEDULE 13G/A Filing
Jan 16, 2025 8-K Current Report
Dec 3, 2024 144 Filing
Nov 12, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals